Guest guest Posted December 13, 2003 Report Share Posted December 13, 2003 Dr. Jon was a little bit of a huckster but I think that most people got value received when they bought vitamins. At least he was promoting nutrition etc. Can you imagine the kind of person who tracked him down and reported him and for what reason? http://www.sun-sentinel.com/news/local/palmbeach/sfl-pfason13dec13,0,6624045.sto\ ry?coll=sfla-news-palm Millionaire's complex past delays day of reckoning By Peter Franceschina Staff Writer Posted December 13 2003 Former Palm Beach millionaire Stewart Fason has lived many lives -- real estate investor, author, stockbroker, computer whiz, philanthropist, alternative-medicine guru and finally, wily fugitive. These days, he's a federal inmate. The outlines of his past so intrigued a federal judge on Friday that he wasn't sentenced to prison for tax evasion. The judge postponed the day of reckoning, until he could learn more about Fason's five years on the run and the medical conditions his attorneys say now threaten his life. = 4)) { // if Flash v4 (or greater) is present flash = true; } else { // if Flash v4 (or greater) is NOT present flash = false; }; //--> '); document.write(' '); document.write(' '); document.write(' '); document.write(' '); document.write(' '); document.write(' '); document.write(''); document.write(''); document.write(''); document.write(''); } else { document.write(''); document.write(''); document.write(''); } // --> There may be some irony that Fason was brought down by the very technology that helped make him rich. An anonymous tipster who used the Internet to research Fason -- he was reportedly hawking an anti-aging cream online under the name Dr. Jon Brooks -- discovered his real identity and that there was a warrant for his arrest. After a call to authorities in West Palm Beach in June, federal agents found Fason living in South Carolina under his brother's name. For a few, futile hours, Fason denied his true identity before admitting he was the man they were looking for. Fason, 70, didn't shy from notoriety in the 1980s. He claimed to have discovered a 19-year-old virtuoso violin player on a New York City street corner, but it was a publicity stunt to promote young musicians he supported. He said his talking cat gave financial advice. He touted a pill he claimed help cure his wife's cancer. He built up a chain of computer stores that brought in millions of dollars just as the PC was being popularized, and he donated his Palm Beach mansion to charity. Back then, though, he was cheating the government on his taxes, according to the U.S. Department of Justice. He purportedly bought the rights to market several B movies in foreign countries for $1.5 million, according to court records, and wrote his loss off on his taxes. The whole thing was a sham, said Justice Department trial attorney Patrick Pericak, who is serving as the prosecutor in the case. Fason's attorneys are asking U.S. District Judge Daniel T.K. Hurley to free Fason, who is being held without bond, so he can have surgery for heart problems. Pericak told the judge there is no way to guarantee Fason wouldn't disappear again, as he did in 1997 when he knew prosecutors were first investigating him for tax evasion in the early 1980s. " The risk of flight in this case is enormous, " Pericak said. " It's the secret assets the government is concerned about. We have no idea about these. " He read from a section of a book written by Fason, A License to Steal, in which he explains how to set up secret bank accounts under aliases. Pericak told the judge Fason produced a letter from a Mexican doctor in 1997 saying Fason had lung cancer and only months to live, as the IRS was investigating his finances. When federal agents arranged for Fason to come from Mexico to San Diego to see another doctor, he never showed, Pericak said. Fason was indicted in July 1998 in West Palm Beach. By then, he couldn't be found. Several years later, unknown to federal agents, he took out driver's licenses in his brother's name in Arkansas and South Carolina, and a passport as well. Fason, under the name Jon Brooks, took out personal ads on seeking companionship. Brooks listed his interests as alternative medicine, tennis, writing, sailing, dancing and good conversation, according to a copy of the ad Pericak included in a court filing. " It looks like he's living care-free, that he doesn't have health problems, " Pericak told the judge. Fason's attorney, Alan Ross, told the judge Fason was willing to post a $2 million bond so he could be released to get medical treatment. Ross also said Fason didn't know that there was a warrant out for his arrest for those five years and that federal agents never sought out Fason's family members to find out where he was. " This is not the case of a man arrested who absconded, " Ross said. The judge disagreed. " I have to assume he was avoiding detection, " Hurley said. Pericak opposed Fason's release, saying he was capable of assuming multiple identities and had unknown resources he could use to vanish. Fason, he said, tried to liquidate a $1.6 million brokerage account from jail. That was after Fason pleaded guilty to a single count of tax evasion in October. Fason faces about two years in prison, when he's sentenced. " He dealt in millions of dollars throughout all of his years, " said Pericak, adding that Fason is now involved with selling an anti-aging cream called Raiza Crème, which is named after his wife. " I think this business is a very big business and making a lot of money. " Hurley said he was concerned that Fason get the medical treatment he needs, but he also seemed reluctant to set bond for Fason. The issues are complex, he told the attorneys, and he said he wants to know more about Fason and whether there might be a way to release him while establishing safeguards that would guarantee his return. The judge said he would let the attorneys know in the next few weeks when the next hearing would take place. " You all have told me enough to want to hear the whole story, " Hurley said. " I want to know all the rest of this. " Peter Franceschina can be reached at pfranceschina@ sun-sentinel.com or 561-832-2894. 2003, South Florida Sun-Sentinel NEW WEB MESSAGE BOARDS - JOIN HERE. Alternative Medicine Message Boards.Info http://alternative-medicine-message-boards.info New Photos - easier uploading and sharing Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 13, 2003 Report Share Posted December 13, 2003 , " Eloise Bailey " <pray@w...> wrote: > > >>>>I do hope that he gets his just deserts because the slimming pills that he was selling were not good, as JoAnn will tell you, she thankfully put me off getting them.>>>>>>> I just happen to have enough of The Formula for another month. Just what was the reason the formula " was not good. " ? I'd really like to know. Eloise Hi Eloise! This was a personal choice by Marianne when she discovered the harmful ingredients these pills contain. In addition,I would also like to emphasize that at that time, Marianne had serious blockages in her arteries ( two major arteries which were blocked 80% and 60% respectively)! She was given six months to live at the max. We're very happy to say now that the correct organic diet and certain heart healthy supplements have since changed all that! Her cholesterol is normal,the high blood pressure and blocked arteries are now healed as well. The Miracles of Alternative Medicine in action! According to the ingredient list that Marianne initially presented me with, Dr. Jon's supplements contained CLA which is basically a transfatty acid (hydrogenated fat) in one of its worst forms! Studies at Harvard and elsewhere confirm that transfats in any form contribute to and are a major factor in cardiovascular (heart and artery) disease! The following passage taken from Udo's site emphasizes this! " •In mice fed an atherogenic diet containing 5g/kg (0.5%) of CLA, CLA increased the development of fatty streaks (abnormal blood clots leading to clogged arteries and heart attacks!), one of the atherogenic markers. " Knowing that Udo Erasmus warns of the dangers of CLA I passed this information on to Marianne. The dangers are very real and more importantly CLA destroys essential fatty acid stores (EFAs) as well! Here is some information on the subject taken from Udo's site.... http://www.udoerasmus.com/articles/udo/cla1_pv.htm CLA: conjugated linoleic acid, a trans- fatty acid made from the n-6 essential linoleic acid by bacterial or by industrial partial hydrogenation. CLA at high doses competes with EFAs and crowds them and their derivatives out of enzyme spaces. This is cause for serious great concern. The body has no requirement for CLA. But it has an absolute requirement for EFAs, which should not be interfered with. What Should be our Focus? We recall that EFAs cannot be made by the body, must be present for the normal (healthy) functioning of every cell, tissue, gland, and organ, and must therefore be provided by foods. EFAs come in two varieties: n-3 and n-6. Both are essential. Both are sensitive to destruction. N-3 is too low for good health in most people's diet. Low and no fat diets are too low in n-3 and n-6. N-6 is too low in people who use flax oil exclusively as the source of EFAs in their diet (these are primarily people who have been misled, by research on the benefits of n-3s and problems caused by n-6s, to seek to remove n-6s from their diet. It is important to obtain BOTH EFAs in the most beneficial ratio, which we find to be 2 n-3s to each n-6. It is also important that our EFAs come from oils that retain their `minor ingredients', which include antioxidants, phytosterols, lecithin, and other oil-soluble molecules present in seeds and nuts. These `minor ingredients' have major health benefits. When colorless, odorless, tasteless, shelf-stable oils are made, the `minor ingredients' are removed from oils for the sake of longer shelf life. In addition, some of the fatty acid molecules present in the oil are changed from natural to toxic. The toxicity from n-6 oils, (corn and safflower) result primarily from the removal of `minor ingredients' and damage to fatty acids due to careless processing. Summary and Recommendations: Bottom Line-- Instead of using CLA, we need in our diet EFAs made with health in mind, in an optimal n-3: n-6 ratio, pressed from organically grown seeds, and retaining their natural antioxidants, phytosterols, and other `minor ingredients'. Being far less expensive than CLA, such oils can be taken in the 30 to 150 gram/day range over the long term, and confer all of the health benefits hyped for but not delivered by CLA. " Forget CLA, and remember EFA. " • Research Studies Of 139 references pulled off the Internet in June of 2001, 29 were published in 2001; 65 in 2000; 33 in 1999; and 15 in 1998.Unfortunately, a substantial number of these studies indicate that CLA does not do in human studies what it appears to do in animal studies. The negative changes induced by CLA include: • At 2% of food, CLA accelerates the decomposition of storage lipids, resulting in lipid 'peroxidation' and morphological change in the liver; • • At 1% of feed in mice, CLA increased TNFa (tumor necrosis factor alpha, an inflammatory factor) by 12 times, and uncoupling protein UCP-2 (a thermogenic factor) by 6 times; there was liver swelling, • increased insulin resistance, and leptin depletion;34 • • Given to rats at 3 to 5%, CLA changes the membrane lipids, increasing some and decreasing others, increases antioxidant enzymes in liver, and reduces both LDL and HDL cholesterol; • • In rats given 180mg/day of mixed isomers, CLA was found to compete for enzymes used to elongate and desaturate EFAs, • thereby decreasing the production of EFA derivatives important to health;38 • • At 10g/kg (1%), CLA reduced rate of bone formation in rats, while EFAs enhanced bone growth; • • In mice fed an atherogenic diet containing 5g/kg (0.5%) of CLA, CLA increased the development of fatty streaks (abnormal blood clots leading to clogged arteries and heart attacks!), one of the atherogenic markers; If the Results are Mediocre, what Drives the Research? What drives the research behind CLA? The dairy and red meat industries might want to use CLA to prop up products that are losing popularity. The hydrogenation industry might like to make these expensive products from cheap oils abundantly available by using existing (trans- fatty acid-making) machinery. Hydrogenation is a process that has lost a great deal of credibility. Most of the CLA studies were carried out in university departments of food technology, animal science, and dairy. Hershey (a US chocolate manufacturer) carried out the milk chocolate study. Let's Run Some Numbers-- Cream, nature's richest natural source of CLA, contains 5mg/gram (0.5%) of fat. The dairy isomer of CLA is mostly c9,t11-18:2. That much is apparently safe and desirable for calves. That much CLA in butter is probably safe for humans as well. At 0.5% CLA, a tablespoon (14 grams) of butter provides about 70mg of CLA.To get 3 grams of CLA from butter, one would need to eat more than 40 tablespoons of it, which is 560 grams of 1.25 pounds of butter. That's a lot more than can be recommended, even if EFA intake is optimal (about 1 tablespoon/body weight in winter; less in summer), the level that makes skin soft and velvety (more in winter, less in summer). By the way, 560 grams of butter is 560 x 0.8 (butter is 20% water) x 9 (calories per gram) = 4,032 calories. Butter, nature's richest source of CLA, does not provide any creature with very much of it. This may explain why high levels result in disturbing negative (side) effects. In commercial preparations, the c9,t11- isomer is found mixed with much higher amounts of the t10,c12-18:2 isomer, along with smaller amounts of the other six CLA isomers .. Each of these has different properties and will therefore have different effects on cell and tissue biochemistry. The specific effects of all isomers are not yet known, but need to be known before safe recommendations for this new mixture of CLA isomers is recommended for health. Regards, JoAnn References: • French P et al. Fatty acid composition, including conjugated linoleic acid, of intramuscular fat from steers offered grazed grass, grass silage, or concentrate-based diets. J Anim Sci 2000 Nov; 78(11): 2849-55. • Eulitz K et al. Preparation, separation, and confirmation of the eight geometrical cis/trans conjugated linoleic acid isomers 8,10- through 11,13-18:2. Lipids 1999 Aug; 34(8): 873-7. • Ma DW et al. Conjugated linoleic acid in Canadian dairy and beef products. J Agric Food Chem 1999 May; 47(5): 1956-60. • Bauman DE et al. Technical note: production of butter with enhanced conjugated linoleic acid for use in biomedical studies with animal models. J Dairy Sci 2000 Nov; 83(11): 2422-5. • Hurst WJ et al. Determination of conjugated linoleic acid (CLA) concentrations in milk chocolate. J Agric Food Chem 2001 Mar; 49(3): 1264-5. • Jung MO et al. Effects of temperature and agitation rate on the formation of conjugated linoleic acids in soybean oil during hydrogenation process. J Agric Food Chem 2001 Jun; 49(6): 3010-6. • Ogawa J et al. Conjugated Linoleic Acid Accumulation via 10- Hydrozy-12-Octadecaenoic Acid during Microaerobic Transformation of Linoleic Acid by Lactobacillus acidophilus. Appl Environ Microbiol 2001 Mar; 67(3): 1246-52. • Chuang LT et al. Effect of conjugated linoleic acid on fungal delta6-desaturase activity in a transformed yeast system. Lipids 2001 Feb 36(2): 139-43. • Sisk MB et al. Dietary conjugated linoleic acid reduces adiposity in lean but not obese zucker rats. J Nutr 2001 Jun; 13(6): 1668-74. • Bulgarella JA et al. Modulation of prostaglandin H synthase activity by conjugated linoleic acid (CLA) and specific CLA isomers. Lipids 2001 Apr; 36(4): 407-12. • Rahman SN et al. Effects of conjugated linoleic acid on serum leptin concentration, body-fat accumulation, and beta- oxidation of fatty acid in OLETF rats. Nutrition 2001 May; 17(5): 385-90. • Ryder JV et al. Some-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes 2001 May; 50(5): 1149-57. • Miner JL et al. Conjugated linoleic acid (CLA), body fat, and apoptosis. Obes Res 2001 Feb; 9(2): 129-34. • Bassaganya-Riera J et al. Effects of dietary conjugated linoleic acid in nursery pigs of dirty and clean environments on growth, empty body composition, and immune competence. J Anim Sci 2001 Mar; 79(3): 714-21. • Whigham LD et al. CLA reduces antigen-induced histamine and PGE(2) release from sensitized guinea pig tracheae. Am J Physiol Regul Integr Comp Physiol 2001 Mar; 280(3): R908-12. • Thomas Yeung CH et al. Dietary conjugated linoleic acid mixture affects the activity of intestinal acyl coenzyme A: cholesterol acyltransferase in hamsters. Br J Nutr 2001 Dec; 84(6): 935-41. • Hubbard NE et al. Reduction of murine mammary tumor metastasis by conjugated linoleic acid. Cancer Lett 2000 Mar 13; 150 (1): 93-100. • McCarty MF. Activation of PPARgamma may mediate a portion of the anticancer activity of conjugated linoleic acid. Med Hypotheses 2000 Sep; 55(3): 187-8. • Bee G. Dietary conjugated linoleic acids alter adipose tissue and milk lipids of pregnant and lactating sows. J Nutr 2000 Sep; 130(9): 2292-8. • Yang M et al. Dietary conjugated linoleic acid protects against end stage disease of systemic jupus erythematosus in the NZB/W F1 mouse. Immunopharmacol Immunotoxicol 2000 Aug; 22(3): 433- 49. • Azain MJ et al. Dietary conjugated linoleic acid reduces rat adipose tissue cell size rather than cell number. J Nutr 2000 Jun; 130(6): 1548-54. • Stangl GL. Conjugated linoleic acid exhibits a strong fat-to- lean partitioning effect, reduce serum VLDL lipids and redistribute tissue lipids in food-restricted rats. J Nutr 2000 May; 130(5): 1140- 46. • Twibell RG et al. Effects of dietary conjugated linoleic acids on hepatic and muscle lipids in hybrid striped bass. Lipids 2000 Feb; 35(2): 155-61. • Baumgard LH et al. Identification of the conjugated linoleic acid isomer that inhibits milk fat synthesis. Am J Physiol Regul Integr Comp Physiol 2000 Jan; 278(1): R179-84. • Yamasake M et al. Dietary conjugated linoleic acid increases immunoglobulin productivity of Sprague-Dawley rat spleen lymphocytes. Biosci Biotecnol Biochem 2000 Oct; 64(10): 2159-64. • Park Y et al. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 1999 Mar; 34(3): 235-41. • Banni S et al. Decrease in linoleic acid metabolites as a potential mechanism in cancer risk reduction by conjugated linoleic acid. Carcinogenesis 1999 Jun; 20(6): 1019-24. • Banni S et al. An increase in vitamin A status by the feeding of conjugated linoleic acid. Nutr Cancer 1999; 33(1): 53-7. • Cesano A et al. Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. Anticancer Res 1998 May-Jun; 18(3A): 1429-34. • Sugano M et al. Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats. Lipids 1998 May; 33(5): 521-7. • Aydin R et al. Olive oil prevents the adverse effects of dietary conjugated linoleic acid on chick hatchability and egg quality. J Nutr 2001 Mar; 13(3): 800-6. • Yamasaki M et al. Effect of dietary conjugated linoleic acid on lipid peroxidation and histological changes in rat liver tissues. J Agric Food Chem 2000 Dec; 48(12): 6367-71. • Du M et al. Effects of dietary conjugated linoleic acid and linoleic:linolenic acid ratio on polyunsaturated fatty acid status in laying hens. Poult Sci 2000 Dec; 79(12): 1749-56. • Tsuboyama-Kasaoka N et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetics 2000 Sep; 49(9): 1543-42. • Latour MA et al. Effects of conjugated linoleic acid. 1. Fatty acid modification of yolks and neonatal fatty acid metabolism. Poult Sci 2000 Jun; 79(6): 817-21. • Stangl GL. High dietary levels of a conjugated linoleic acid mixture alter hepatic glycerophopholipid class profile and cholesterol-carrying serum lipoproteins of rats. J Nutr Biochem 2000 Apr 1; 11(4): 184-91. • de Deckere EA et al. Effects of conjugated linoleic acid (CLA) isomers on lipid levels and peroxisome proliferation in the hamster. Br J Nutr 1999 Oct; 82(4): 309-17. • Sebodio JL et al. Geometry of conjugated bonds of CLA isomers in a commercial mixture and their hepatic 20:4 metabolites. Lipids 1999 Dec; 34(12): 1319-25. • Li Y et al. Dietary conjugated linoleic acid alter serum IGF_1 and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. J Bone Miner Res 1999 Jul; 14(7): 1153062. • Munday JS et al. Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model. Br J Nutr 1999 Mar; 81(3): 251-5. • Petrik MB et al. Highly unsaturated )n-3) fatty acids, but not alpha-linolenic, conjugated linoleic, or gamma-linolenic acids, reduce tumorigenesis in Apc(Min/+) mice. J Nutr 2000 Oct; 130(10): 1434-43. • Benito P et al. The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids 2001 Mar; 36(3): 229-36. • Benito P et al. The effect of conjugated linoleic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 2001 Mar; 36(3): 221-7. • Elias SL, Innis SM. Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. Am J Clin Nutr 2001 Apr; 73(4): 807-14. • Kelly DS et al. Dietary conjugated linoleic acid did not alter immune status in young healthy women. Lipids 2000 Oct; 35(10): 1065071. • Basu S et al. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clin Sci (Colch) 2000 Dec; 99(6): 511-6. • Lucchi L et al. Changes in conjugated linoleic acid and its metabolites in patients with chronic renal failure. Kidney Int 2000 Oct; 58(4): 1695-702. • Medina EA et al. Conjugated linoleic acid supplementation in humans: effects on circulating leptin concentrations and appetite. Lipids 2000 Jul; 35(7): 783-8. • Zambell KI et al. Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids 2000 Jul; 35(7): 777-82. • Basu S et al. Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Lett 2000 Feb 18; 468(1): 33-6. • Blankson H et al. Conjugated linoleic acid reduces body fat in overweight and obese humans. J Nutr 2000 Dec; 1301(12): 2943-8. • Herbel BK et al. Safflower oil consumption does not increase plasma conjugated linoleic acid in humans. Am J Clin Nutr 1998 Feb; 67(2): 332-7. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.